SCHEMBL16169367

SCHEMBL16169367

CC(C)(C)OC(=O)N[C@H]1CCCC[C@H]1Nc1nc(Nc2cccc(-n3ccnn3)c2)c(C(N)=O)cc1F

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 18/20 0.57
▸ KCNH2 Q12809 1/20 0.44
▸ FER P16591 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19790653 0.91 SYK (0.66) SYKKCNH2FER
SCHEMBL16165491 0.89 SYK (0.62) SYKKCNH2FER
SCHEMBL16169366 0.88 SYK (0.58) SYKKCNH2
SCHEMBL16169189 0.88 SYK (0.46) SYKFER
SCHEMBL9107832 0.86 SYK (0.74) SYKKCNH2FER
SCHEMBL14911394 0.86 SYK (0.74) SYKKCNH2FER
SCHEMBL14910430 0.86 SYK (0.74) SYKKCNH2FER
SCHEMBL16169271 0.85 SYK (0.56) SYK
SCHEMBL16169369 0.85 SYK (0.58) SYKFER
SCHEMBL16169363 0.85 FER (0.60) SYKKCNH2FER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-10-16 — — US disclosed
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, BTK, NOX4 SYK 1/4885KCNH2 1953/4885FER 441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback